0001104659-20-084577.txt : 20200717
0001104659-20-084577.hdr.sgml : 20200717
20200717172729
ACCESSION NUMBER: 0001104659-20-084577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200715
FILED AS OF DATE: 20200717
DATE AS OF CHANGE: 20200717
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blumenkranz Mark S.
CENTRAL INDEX KEY: 0001614869
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 201034479
MAIL ADDRESS:
STREET 1: C/O 1LIFE HEALTHCARE, INC.
STREET 2: ONE EMBARCADERO CENTER, SUITE 1900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IVERIC bio, Inc.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208185347
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
FORMER COMPANY:
FORMER CONFORMED NAME: Ophthotech Corp.
DATE OF NAME CHANGE: 20070828
4
1
a4.xml
4
X0306
4
2020-07-15
0
0001410939
IVERIC bio, Inc.
ISEE
0001614869
Blumenkranz Mark S.
C/O IVERIC BIO, INC.
ONE PENN PLAZA, 35TH FLOOR
NEW YORK
NY
10119
1
0
0
0
Stock Option (Right to Buy)
4.48
2020-07-15
4
A
0
31000
0
A
2030-07-14
Common Stock
31000
31000
D
Restricted Stock Units
2020-07-15
4
A
0
15000
0
A
Common Stock
15000
15000
D
Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable monthly with respect to 1/36th of the shares underlying such option until the third anniversary of the grant date.
Each restricted stock unit represents the contingent right to receive one share of common stock of the Registrant upon vesting of the unit.
Subject to the Reporting Person providing continued services to the Registrant and the other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the award of the restricted stock units will vest annually with respect to 1/3rd of the shares underlying such award until the third anniversary of the grant date.
/s/ Todd D.C. Anderman, as Attorney-in-Fact for Mark S. Blumenkranz
2020-07-17